Today, the VP, General Counsel & Sec’y. of 22nd Century (NYSE MKT: XXII), Thomas L. James, sold shares of XXII for $121.5K.
See today’s analyst top recommended stocks >>
Based on 22nd Century’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $6.12 million and quarterly net profit of $1.39 million. In comparison, last year the company earned revenue of $3.9 million and had a GAAP net loss of $3.36 million. Currently, 22nd Century has an average volume of 2.09M.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding.
